Search details
1.
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy.
Nature
; 629(8010): 201-210, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38600376
2.
Enterotoxins can support CAR T cells against solid tumors.
Proc Natl Acad Sci U S A
; 116(50): 25229-25235, 2019 12 10.
Article
in English
| MEDLINE | ID: mdl-31767744
3.
Reprogramming the tumor microenvironment to enhance adoptive cellular therapy.
Semin Immunol
; 28(1): 64-72, 2016 02.
Article
in English
| MEDLINE | ID: mdl-26611350
4.
Insights into Cancer Immunotherapies: Recent Breakthroughs, Opportunities, and Challenges.
Cancers (Basel)
; 15(4)2023 Feb 19.
Article
in English
| MEDLINE | ID: mdl-36831663
5.
Naïve blood monocytes suppress T-cell function. A possible mechanism for protection from autoimmunity.
Immunol Cell Biol
; 89(1): 7-13, 2011 Jan.
Article
in English
| MEDLINE | ID: mdl-21060323
6.
Enhancing co-stimulation of CAR T cells to improve treatment outcomes in solid cancers.
Immunother Adv
; 1(1): ltab016, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-35919743
7.
Cross-talk between tumors at anatomically distinct sites.
FEBS J
; 288(1): 81-90, 2021 01.
Article
in English
| MEDLINE | ID: mdl-32248616
8.
Understanding T cell phenotype for the design of effective chimeric antigen receptor T cell therapies.
J Immunother Cancer
; 9(5)2021 05.
Article
in English
| MEDLINE | ID: mdl-34035114
9.
Cellular networks controlling T cell persistence in adoptive cell therapy.
Nat Rev Immunol
; 21(12): 769-784, 2021 12.
Article
in English
| MEDLINE | ID: mdl-33879873
10.
Enhancing Adoptive Cell Transfer with Combination BRAF-MEK and CDK4/6 Inhibitors in Melanoma.
Cancers (Basel)
; 13(24)2021 Dec 17.
Article
in English
| MEDLINE | ID: mdl-34944961
11.
A Histone Deacetylase Inhibitor, Panobinostat, Enhances Chimeric Antigen Receptor T-cell Antitumor Effect Against Pancreatic Cancer.
Clin Cancer Res
; 27(22): 6222-6234, 2021 11 15.
Article
in English
| MEDLINE | ID: mdl-34475103
12.
Challenges and Opportunities for Effective Cancer Immunotherapies.
Cancers (Basel)
; 12(11)2020 Oct 28.
Article
in English
| MEDLINE | ID: mdl-33126513
13.
Primary and metastatic breast tumors cross-talk to influence immunotherapy responses.
Oncoimmunology
; 9(1): 1802979, 2020 08 30.
Article
in English
| MEDLINE | ID: mdl-32939322
14.
Enhancing chimeric antigen receptor T-cell immunotherapy against cancer using a nanoemulsion-based vaccine targeting cross-presenting dendritic cells.
Clin Transl Immunology
; 9(7): e1157, 2020.
Article
in English
| MEDLINE | ID: mdl-32704371
15.
Novel combination immunotherapy for pancreatic cancer: potent anti-tumor effects with CD40 agonist and interleukin-15 treatment.
Clin Transl Immunology
; 9(8): e1165, 2020.
Article
in English
| MEDLINE | ID: mdl-32821382
16.
Genetic Redirection of T Cells for the Treatment of Pancreatic Cancer.
Front Oncol
; 9: 56, 2019.
Article
in English
| MEDLINE | ID: mdl-30809507
17.
Tissue-specific tumor microenvironments influence responses to immunotherapies.
Clin Transl Immunology
; 8(11): e1094, 2019.
Article
in English
| MEDLINE | ID: mdl-31768254
18.
CARs versus BiTEs: A Comparison between T Cell-Redirection Strategies for Cancer Treatment.
Cancer Discov
; 8(8): 924-934, 2018 08.
Article
in English
| MEDLINE | ID: mdl-30012854
19.
Tissue-Dependent Tumor Microenvironments and Their Impact on Immunotherapy Responses.
Front Immunol
; 9: 70, 2018.
Article
in English
| MEDLINE | ID: mdl-29445373
20.
Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4+Foxp3- Cell-Mediated Modulation of CD103+ Dendritic Cells.
Cancer Immunol Res
; 6(9): 1069-1081, 2018 09.
Article
in English
| MEDLINE | ID: mdl-30018045